Cart
sales@molnova.com
ML-030
CAS No. 1013750-77-0
ML-030( —— )
Catalog No. M22080 CAS No. 1013750-77-0
ML-030 is a potent and selective inhibitor of PDE4(PDE4A, PDE4A1, PDE4B1, PDE4B2, PDE4C1,and PDE4D2 with IC50 of 6.7 nM, 12.9 nM, 48.2 nM, 37.2 nM, 452 nM and 49.2 nM, respectively)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 37 | In Stock |
|
| 25MG | 77 | In Stock |
|
| 50MG | 133 | In Stock |
|
| 100MG | 194 | In Stock |
|
| 200MG | 282 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML-030
-
NoteResearch use only, not for human use.
-
Brief DescriptionML-030 is a potent and selective inhibitor of PDE4(PDE4A, PDE4A1, PDE4B1, PDE4B2, PDE4C1,and PDE4D2 with IC50 of 6.7 nM, 12.9 nM, 48.2 nM, 37.2 nM, 452 nM and 49.2 nM, respectively)
-
DescriptionML-030 is a potent and selective inhibitor of PDE4(PDE4A, PDE4A1, PDE4B1, PDE4B2, PDE4C1,and PDE4D2 with IC50 of 6.7 nM, 12.9 nM, 48.2 nM, 37.2 nM, 452 nM and 49.2 nM, respectively)
-
In VitroML-030 is potent in cell-based assay with an EC50 value of 18.7 nM.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1013750-77-0
-
Formula Weight412.46
-
Molecular FormulaC20H20N4O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:45 mg/mL (109.1 mM; Need ultrasonic)
-
SMILESCOc1ccc(OC)c(c1)-c1nnc2SCC(=Nn12)c1ccc(OC)c(OC)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Skoumbourdis AP, et al. Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3686-92.
molnova catalog
related products
-
Homo Sildenafil
Homo Sildenafil is an analog of Sildenafil, It acts as a phosphodiesterase inhibitor.
-
Tovinontrine
Tovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment.
-
SEP-0372814
SEP-0372814 is a potent inhibitor of PDE10.
